Form 8-K - Current report:
SEC Accession No. 0001193125-25-068727
Filing Date
2025-03-31
Accepted
2025-03-31 16:02:11
Documents
19
Period of Report
2025-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d944342d8k.htm   iXBRL 8-K 54725
2 EX-10.1 d944342dex101.htm EX-10.1 781735
3 EX-10.2 d944342dex102.htm EX-10.2 143982
4 EX-99.1 d944342dex991.htm EX-99.1 162931
9 GRAPHIC g944342page1.jpg GRAPHIC 13531
10 GRAPHIC g944342page2.jpg GRAPHIC 9394
  Complete submission text file 0001193125-25-068727.txt   1553032

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20250327.xsd EX-101.SCH 3101
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20250327_def.xml EX-101.DEF 13867
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20250327_lab.xml EX-101.LAB 22898
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20250327_pre.xml EX-101.PRE 14705
21 EXTRACTED XBRL INSTANCE DOCUMENT d944342d8k_htm.xml XML 5888
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 25793030
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)